Oric Pharmaceuticalsinc Stock Analysis

Oric Stock Analysis Notes

About 88.0% of the company shares are owned by institutional investors. The book value of Oric PharmaceuticalsI was now reported as 4.08. The company recorded a loss per share of 1.96. Oric PharmaceuticalsInc had not issued any dividends in recent years. ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. The company was incorporated in 2014 and is headquartered in South San Francisco, California. Oric Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 83 people. To find out more about Oric PharmaceuticalsInc contact MD MBA at 650 388 5600 or learn more at https://www.oricpharma.com.

Oric PharmaceuticalsInc Investment Alerts

Oric PharmaceuticalsInc Upcoming and Recent Events

Oric Largest EPS Surprises

View All Earnings Estimates

Oric Stock Institutional Investors

Note, although Oric PharmaceuticalsI's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Oric Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 636.7 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Oric PharmaceuticalsI's market, we take the total number of its shares issued and multiply it by Oric PharmaceuticalsI's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Oric Profitablity

Management Efficiency

Oric PharmaceuticalsInc has return on total asset (ROA) of (0.2774) % which means that it has lost $0.2774 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4511) %, meaning that it created substantial loss on money invested by shareholders. Oric PharmaceuticalsI's management efficiency ratios could be used to measure how well Oric PharmaceuticalsI manages its routine affairs as well as how well it operates its assets and liabilities. As of April 18, 2024, Return On Tangible Assets is expected to decline to -0.42. In addition to that, Return On Capital Employed is expected to decline to -0.5. At present, Oric PharmaceuticalsI's Debt To Assets are projected to increase slightly based on the last few years of reporting.

Technical Drivers

As of the 18th of April 2024, Oric PharmaceuticalsI holds the Risk Adjusted Performance of 0.0469, coefficient of variation of 2647.07, and Semi Deviation of 4.22. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Oric PharmaceuticalsI, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to collect and analyze data for nineteen technical drivers for Oric PharmaceuticalsInc, which can be compared to its competitors. Please check Oric PharmaceuticalsInc treynor ratio, and the relationship between the variance and potential upside to decide if Oric PharmaceuticalsInc is priced some-what accurately, providing market reflects its current price of 9.51 per share. Given that Oric PharmaceuticalsI has jensen alpha of 0.2113, we recommend you to check out Oric PharmaceuticalsInc's recent market performance to make sure the company can sustain itself at a future point.

Oric PharmaceuticalsInc Price Movement Analysis

Oric PharmaceuticalsInc Insider Trading Activities

Oric PharmaceuticalsI Predictive Daily Indicators

Oric PharmaceuticalsI Corporate Filings

Oric PharmaceuticalsI Forecast Models

Oric PharmaceuticalsI's time-series forecasting models are one of many Oric PharmaceuticalsI's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Oric PharmaceuticalsI's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Oric PharmaceuticalsI prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Oric shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Oric PharmaceuticalsI. By using and applying Oric Stock analysis, traders can create a robust methodology for identifying Oric entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Oric analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Oric analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Oric PharmaceuticalsInc stock analysis indicators help investors evaluate how Oric PharmaceuticalsI stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Oric PharmaceuticalsI shares will generate the highest return on investment. By understating and applying Oric PharmaceuticalsI stock analysis, traders can identify Oric PharmaceuticalsI position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oric PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

When running Oric PharmaceuticalsI's price analysis, check to measure Oric PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oric PharmaceuticalsI is operating at the current time. Most of Oric PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Oric PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oric PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Oric PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.

Is Oric PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oric PharmaceuticalsI. If investors know Oric will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oric PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Oric PharmaceuticalsInc is measured differently than its book value, which is the value of Oric that is recorded on the company's balance sheet. Investors also form their own opinion of Oric PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Oric PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oric PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Oric PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Oric PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oric PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oric PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.